Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...

Saquon Barkley consulted with his family before the star running back decided — yes, it was time to leave his only professional home with the Giants and sign with the Eagles.

Daniels’ completion rate dipped from 69.7 percent to 65.8 percent after his 29-of-48 performance in Philadelphia, but he still edged out Brock Purdy for best rookie completion rate in a single ...

But Barkley humbled this defense back in Week 12, with 255 rushing yards and 47 receiving yards. Rookie edge rusher Jared Verse has excelled at pressuring the quarterback, but he failed to set the ...

Barkley ran for touchdowns of 70 and 72 yards in the second half and finished with 255 yards on the ground, an Eagles rushing record. It was the ninth-most rushing yards in a game in NFL history ...